GlassScriptPhysician profile
Michael J Martin
NPI 1790726768
$1,525.54
in general payments reported to CMS, 2019-2025
14 companies · $69.46 in 2025
The $69.46 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $359 · 2020: $321 · 2021: $410 · 2022: $198 · 2023: $164 · 2024: $4.68 · 2025: $69.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $237.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $1,001.10 | 2019-2022 | |
| Polynovo North America LLC | $91.33 | 2023 | |
| Stryker Corporation | $85.52 | 2019 | |
| Zimvie INC. | $55.28 | 2022-2023 | |
| Medtronic, INC. | $52.62 | 2023 | Mazor X System |
| Avanos Medical | $50.56 | 2019 | |
| Baxter Healthcare | $49.69 | 2025 | Perclot |
| Cerapedics INC. | $31.91 | 2022 | |
| Nevro Corp. | $24.89 | 2019 | |
| Radius Health, INC. | $23.12 | 2019 | |
| Amgen INC. | $19.77 | 2025 | Prolia, Evenity |
| Boston Scientific Corporation | $18.56 | 2019 | |
| Depuy Synthes Sales INC. | $16.51 | 2022 | |
| Saluda Medical Americas, INC. | $4.68 | 2024 | Evoke |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.